Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis
The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients.
Focal ablation yields lower treatment failure rates than surgery for prostate cancer
This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy.
How radiotherapy protects the hearts of breast cancer patients
The study's authors reviewed CCTA imaging results taken before and after radiotherapy, evaluating each image for signs of coronary calcification and inflammation.
Imaging helps guide antidepressant medication choices
New research may help providers identify patterns on neuroimaging that could offer clues into how well patients are responding to antidepressant medications.
Sterile, temperature-controlled preservation reduces long-term mortality after heart transplant by 54%
An advanced preservation system from Paragonix, a Getinge company, was linked to dramatic reductions in both mortality and procedural complications.

New patient-specific heart models could change how cardiologists make treatment decisions

The 3D-printed models are soft, flexible and can mimic the way a patient's heart may respond to different interventions.

Confirmed: Long COVID more than doubles a person’s risk of heart issues

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications.

Tim Attebery, DSc, MBA, the CEO of Cardiovascular Associates of America and former CEO of the American College of Cardiology (ACC)

Q&A: Tim Attebery on why private equity-backed management companies are investing in cardiology

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology.

New ACC/AHA/SCAI guidance highlights training requirements for interventional cardiologists

The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies.

Virtual learning left some radiology residents feeling uncomfortable completing procedures

Some residents recently indicated that virtual learning environments led them to having little-to-no procedural training at all in certain subspecialties.

The increased use of implantable loop recorders (ILRs) is associated with identifying more bradyarrhythmias such as bradycardia, according to new findings published in JAMA Cardiology.

Increased AFib screening improves bradyarrhythmia detection—but is it a mixed blessing?

When long-term continuous monitoring detects bradyarrhythmia in an asymptomatic patient, is it still providing value?

Bertram Pitt, MD, a professor of medicine emeritus at the University of Michigan School of Medicine, explains the role of sodium–glucose co-transporter-2 (SGLT-2) inhibitors for heart failure (HF). Initially developed to treat diabetes, these drugs have been shown to improve HF outcomes in HF in several large, randomized trials over the past few years, including SOLOIST-WHF, DAPA-HF, EMPEROR-Preserved, and the DELIVER trials. The positive results earned their inclusion in the 2022 AHA/ACC/HFSA Guideline for

What clinical research tells us about sotagliflozin and heart failure

Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more.

Some long COVID patients display 'severe' changes in their brain

For patients with anxiety and depression, even mild cases of long COVID could result in functional and structural alterations of the brain.

Clinical

A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis

Focal ablation yields lower treatment failure rates than surgery for prostate cancer

How radiotherapy protects the hearts of breast cancer patients

Imaging helps guide antidepressant medication choices

Sterile, temperature-controlled preservation reduces long-term mortality after heart transplant by 54%